Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz
|Bid||1.51 x 500|
|Ask||2.05 x 800|
|Day's Range||1.72 - 1.82|
|52 Week Range||1.50 - 3.88|
|PE Ratio (TTM)||-0.70|
|Earnings Date||Nov 13, 2017 - Nov 17, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||7.00|
MADISON, Wis., Sept. 21, 2017-- Cellectar Biosciences, Inc., an oncology-focused, clinical stage biotechnology company, and Onconova Therapeutics today announced that they have entered into a strategic ...
NEWTOWN, Pa., Sept. 05, 2017-- Onconova Therapeutics, Inc., a Phase 3- stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic ...
Q2 2017 Onconova Therapeutics Inc Earnings Call